Özlem Türeci
Özlem Türeci is a prominent Turkish-German physician and entrepreneur, best known as a co-founder of BioNTech, a biotechnology company that gained international acclaim for developing one of the first effective COVID-19 vaccines using mRNA technology. Türeci, along with her husband Ugur Sahin, has been instrumental in advancing innovative therapies for cancer, leveraging the same mRNA technology to enhance the immune system's ability to fight cancer cells. Recently, she was in the news due to a significant partnership between BioNTech and Bristol Myers Squibb to develop and commercialize a new cancer drug aimed at enhancing immune responses against tumors, reflecting her ongoing contributions to both cancer research and immunotherapy.
Not in the pool (under ¢1).
Recent news mentions
BioNTech co-founder Özlem Türeci has worked in the same lab as Kaddu-Mulindwa.
Bauchspeicheldrüsenkrebs: Tückisch und oft erst spät erkannt
Luxembourg· 2026-02-04
Özlem Türeci is one of the founders of BioNTech, which focuses on long-term strategies.
«Die Pipeline von Roche könnte für den nächsten Wachstumsschub sorgen»
Switzerland· 2025-10-12
Özlem Türeci and Uğur Şahin are the Turkish immigrants behind Covid vaccine pioneer BioNTech.
Germany urgently needs to attract migrant workers – it just doesn’t want them to feel welcome | Chris Reiter and Will Wilkes
United Kingdom· 2025-06-27
Özlem Türeci is one of the founders of Biontech, which was recently awarded the Deutscher Nationalpreis 2025.
Biontech: Vorbild für die deutsche Industrie - Wirtschaft
Germany· 2025-06-13
Özlem Türeci is one of the founders of Biontech who received the Nationalpreis for their entrepreneurial and scientific achievements.
Nationalpreis: Merz hält Laudatio für Biontech-Gründer Türeci und Şahin - WirtschaftGermany· 2025-06-10Özlem Türeci is a co-founder of the German company BioNTech, which is collaborating with Bristol Myers Squibb on cancer drug development.
Kanser ilacı için dev ortaklık
Turkey· 2025-06-04